EverydayHealth
A new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.
When COVID-19 spread across the U.S. in early March, Mayo Clinic’s Advanced Diagnostic Laboratory urgently responded by transitioning lab spaces, reassigning staff, and fast-tracking funding approvals.
Dr. Theel, director, Mayo Clinic Infectious Diseases Serology Laboratory, was recently highlighted in the Star Tribune's special issue featuring heroes of the pandemic.
Matthew Binnicker, Ph.D., Director of Clinical Virology at Mayo Clinic, was recently featured in an interview with Fox News on the COVID-19 infection.
Matthew Binnicker, Ph.D., discusses the need for laboratory testing for the diagnosis and management of fast-spreading viral infections.
Jane Hermansen, MT(ASCP), was recently featured in 360Dx discussing new federal regulations aimed at hospital price transparency.
Rondell Graham, M.B.B.S., an anatomic and molecular consultant at Mayo Clinic, co-led a molecular oncology tumor board session at CAP19, and subsequently spoke with CAP Today.
Elitza Theel, Ph.D., Director of the Infectious Diseases Serology Laboratory, Co-Director of the Vector-Borne Diseases Laboratory, and Associate Professor of Laboratory Medicine and Pathology, was recently interviewed by CAP Today about new Lyme disease testing.
In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide. Rapid and accurate identification of the infection enables directed monitoring of patients who may be at increased risk of developing hemorrhagic fever of dengue shock syndrome.
Antimicrobial susceptibility testing determines whether these bacteria are susceptible or resistant to a particular antibiotic. Bacteria are added onto plates of solid agar, where each plate has a different and increasing concentration of antibiotic than the previous plate. The minimum inhibitory concentration (MIC) is the lowest concentration of an antimicrobial that inhibits growth of the bacteria.
This week's research roundup features research on the phase II evaluation of aggressive dose de-escalation for adjuvant chemoradiotherapy in human pappillomavirus-associated oropharynx squamous cell carcinoma.
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
This week's research roundup features a study on the joint association of mammographic density and polygenic risk score and how they contribute to the prediction of breast cancer.